| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.17 |
0.0007 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.002 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.17 |
0.002 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.003 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
| mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |